BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27784762)

  • 21. Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways.
    Hassett DJ; Sutton MD; Schurr MJ; Herr AB; Caldwell CC; Matu JO
    Trends Microbiol; 2009 Mar; 17(3):130-8. PubMed ID: 19231190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Release of cystic fibrosis airway inflammatory markers from Pseudomonas aeruginosa-stimulated human neutrophils involves NADPH oxidase-dependent extracellular DNA trap formation.
    Yoo DG; Winn M; Pang L; Moskowitz SM; Malech HL; Leto TL; Rada B
    J Immunol; 2014 May; 192(10):4728-38. PubMed ID: 24740504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mannitol Does Not Enhance Tobramycin Killing of Pseudomonas aeruginosa in a Cystic Fibrosis Model System of Biofilm Formation.
    Price KE; Orazi G; Ruoff KL; Hebert WP; O'Toole GA; Mastoridis P
    PLoS One; 2015; 10(10):e0141192. PubMed ID: 26506004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BPI-ANCA is expressed in the airways of cystic fibrosis patients and correlates to platelet numbers and Pseudomonas aeruginosa colonization.
    Hovold G; Lindberg U; Ljungberg JK; Shannon O; Påhlman LI
    Respir Med; 2020; 170():105994. PubMed ID: 32843162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
    Kronborg G
    APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of Pulmozyme activity in purulent sputum by combination with poly-aspartic acid or gelsolin.
    Bucki R; Cruz K; Pogoda K; Eggert A; Chin L; Ferrin M; Imbesi G; Hadjiliadis D; Janmey PA
    J Cyst Fibros; 2015 Sep; 14(5):587-93. PubMed ID: 25682700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient-specific modeling of regional antibiotic concentration levels in airways of patients with cystic fibrosis: are we dosing high enough?
    Bos AC; van Holsbeke C; de Backer JW; van Westreenen M; Janssens HM; Vos WG; Tiddens HA
    PLoS One; 2015; 10(3):e0118454. PubMed ID: 25734630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of DNA on the activities and inhibition of neutrophil serine proteases in cystic fibrosis sputum.
    Dubois AV; Gauthier A; Bréa D; Varaigne F; Diot P; Gauthier F; Attucci S
    Am J Respir Cell Mol Biol; 2012 Jul; 47(1):80-6. PubMed ID: 22343221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.
    Hill D; Rose B; Pajkos A; Robinson M; Bye P; Bell S; Elkins M; Thompson B; Macleod C; Aaron SD; Harbour C
    J Clin Microbiol; 2005 Oct; 43(10):5085-90. PubMed ID: 16207967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting
    Maisetta G; Grassi L; Esin S; Kaya E; Morelli A; Puppi D; Piras M; Chiellini F; Pifferi M; Batoni G
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31861859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Nonantibiotic Macrolide EM703 Improves Survival in a Model of Quinolone-Treated Pseudomonas aeruginosa Airway Infection.
    Kasetty G; Bhongir RKV; Papareddy P; Herwald H; Egesten A
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chelation of Membrane-Bound Cations by Extracellular DNA Activates the Type VI Secretion System in Pseudomonas aeruginosa.
    Wilton M; Wong MJQ; Tang L; Liang X; Moore R; Parkins MD; Lewenza S; Dong TG
    Infect Immun; 2016 Aug; 84(8):2355-2361. PubMed ID: 27271742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aerosol treatment with MNEI suppresses bacterial proliferation in a model of chronic Pseudomonas aeruginosa lung infection.
    Woods DE; Cantin A; Cooley J; Kenney DM; Remold-O'Donnell E
    Pediatr Pulmonol; 2005 Feb; 39(2):141-9. PubMed ID: 15633200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioengineered lysozyme reduces bacterial burden and inflammation in a murine model of mucoid Pseudomonas aeruginosa lung infection.
    Teneback CC; Scanlon TC; Wargo MJ; Bement JL; Griswold KE; Leclair LW
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5559-64. PubMed ID: 23979752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced in vitro formation and antibiotic resistance of nonattached Pseudomonas aeruginosa aggregates through incorporation of neutrophil products.
    Caceres SM; Malcolm KC; Taylor-Cousar JL; Nichols DP; Saavedra MT; Bratton DL; Moskowitz SM; Burns JL; Nick JA
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6851-60. PubMed ID: 25182651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody response against Pseudomonas aeruginosa and its relationship with immune mediators in the upper and lower airways of cystic fibrosis patients.
    Mauch RM; Hentschel J; Aanaes K; Barucha A; Nolasco da Silva MT; Levy CE; Høiby N; Mainz JG
    Pediatr Pulmonol; 2020 Apr; 55(4):959-967. PubMed ID: 32022432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cystic fibrosis sputum DNA has NETosis characteristics and neutrophil extracellular trap release is regulated by macrophage migration-inhibitory factor.
    Dwyer M; Shan Q; D'Ortona S; Maurer R; Mitchell R; Olesen H; Thiel S; Huebner J; Gadjeva M
    J Innate Immun; 2014; 6(6):765-79. PubMed ID: 24862346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotic pressure compensates the biological cost associated with Pseudomonas aeruginosa hypermutable phenotypes in vitro and in a murine model of chronic airways infection.
    Alcalá-Franco B; Montanari S; Cigana C; Bertoni G; Oliver A; Bragonzi A
    J Antimicrob Chemother; 2012 Apr; 67(4):962-9. PubMed ID: 22294647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New approaches to Pseudomonas aeruginosa lower respiratory tract infections.
    Matsumoto K
    Verh K Acad Geneeskd Belg; 1995; 57(2):109-22. PubMed ID: 7571853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of microbicidal activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis.
    Rogan MP; Taggart CC; Greene CM; Murphy PG; O'Neill SJ; McElvaney NG
    J Infect Dis; 2004 Oct; 190(7):1245-53. PubMed ID: 15346334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.